Testing Jornay PM for adult ADHD symptoms into the evening
Part of Mental health clinical trials.
This study tests if Jornay PM, a long-acting ADHD medication, helps control symptoms, focus, and emotions throughout the day and into the early evening in adults with ADHD. It is an open-label study, meaning everyone knows they are getting the medication, and then they are randomly assigned to different observation groups.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 60 years old.
- You have been diagnosed with ADHD (inattentive or combined type).
- You have not taken any stimulant medication for ADHD in the past 2 months.
- You are not currently taking any benzodiazepines or certain other psychiatric medications.
- You do not have a history of severe drug dependence or substance abuse in the past 6 months.
- You are not pregnant, breastfeeding, or planning to become pregnant during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a medication called Foquest to see if it helps older adults with ADHD. It aims to improve attention and reduce hyperactivity or impulsivity in people aged 65 and above.
This trial tests whether the medication Dyanavel XR (a long-acting amphetamine) can help reduce fatigue in adults with ADHD. It is for people who have both ADHD and significant tiredness, and who are not currently taking stimulant ADHD drugs.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This study tests whether CNS stimulant medications can improve irritability and aggression in children with ADHD. It looks for factors that predict who will benefit most.
This study tests whether a long-acting ADHD medication called methylphenidate (Jornay PM) can help young people with both ADHD and cannabis use disorder reduce their cannabis use. It aims to see if treating ADHD symptoms also helps with cannabis problems.
This study tests whether a specific ADHD medication (Jornay PM) is safe and helpful for children who have both epilepsy and ADHD. Researchers want to see if treating ADHD can improve focus and behavior without making seizures worse.
Hear when a new ADHD trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.